XAF1 promoter methylation status of MGMT-hypo (T98G) GBM cell lines was not significantly affected by the transition from treatment naïve (Ctrl) to adaptively resistant (TMZ-R) (Fig. 4f). The gene discussed is MGMT; the disease is glioblastoma.